The United States Food and Drug Administration (FDA) revealed on Friday its latest study found Pfizer Inc. and BioNTech SE’s vaccine against COVID-19 is 90.7% effective against the disease in children aged between five and 11.
The trials were conducted in 2,268 individuals divided into two groups. Those that received both doses of the jab developed an immunity of 90.7% in comparison to those that got a placebo.
Pfizer asked for the FDA’s approval for the use of its treatment in kids earlier this month.
In an unprecedented decision, Turkey stopped, as of Thursday, all its commercial transactions with Israel,…
Poilictian Mohamed Abbou stated Thursday that “he will not partake in the next presidential elections because…
President of the Republic, Kais Saied, welcomed, today, Thursday, May 2, 2024, at Carthage Palace,…
The United Nations Development Programme (UNDP) statedon Thursday that it estimates the reconstruction of the…
It appears from an analysis issued by ITCEQ on “the digitalization of administrative services in…
The commissioner general of the UN Agency for Employment of Palestinian Refugees (UNRWA), Philippe Lazzarini,…
This website uses cookies.